Hyperpigmentation — patches of skin darker than the surrounding tone — is one of the most common and most frustrating concerns, because it fades slowly and returns easily. The frustration usually comes from treating it as one problem when it is really several, each with a different cause and a different realistic timeline.
What they share is the mechanism: pigment-producing cells overproducing melanin in response to some trigger. And what they share as a treatment is the single most important, most overlooked step — sun protection, without which nothing else works.
Know which kind you have
Sun spots (solar lentigines) are flat brown marks from years of ultraviolet exposure, common on the face and hands. Post-inflammatory hyperpigmentation is the brown or tan mark left after a spot, injury or irritation heals — the most common cause of the 'my acne cleared but the marks stayed' complaint, especially in medium to deep skin tones. Melasma is a hormonally influenced, often symmetric patchiness, notoriously stubborn and easily worsened by heat and light.
The distinction matters because melasma needs a gentler, more patient, sometimes medically supervised approach, while post-acne marks often fade substantially on their own with time and protection. Misidentifying the type is why many people's efforts stall.
What actually fades it
The evidence-based toolkit: broad-spectrum sunscreen first and always, because ultraviolet and even visible light re-darken pigment faster than any serum can lighten it. On top of that, ingredients that calm pigment production or speed cell turnover — vitamin C, niacinamide, azelaic acid, alpha hydroxy acids, and retinoids — used consistently over months.
The keyword is months. Pigment sits at different depths, and surface marks fade faster than deeper ones. Anything promising to erase dark spots in days is selling optimism. Steady, gentle, sun-protected consistency is what genuinely works.
Why sunscreen is the whole game
It cannot be overstated: for every kind of hyperpigmentation, daily sunscreen is both treatment and prevention. Without it, brightening actives are bailing water out of a boat with a hole in it — the sun re-triggers the very cells you are trying to calm. For melasma and deeper skin tones especially, a tinted sunscreen that also blocks visible light can matter.
And protect the skin from irritation, because inflammation itself darkens skin — aggressive scrubbing, harsh actives and picking all make marks worse. Fading pigmentation is a slow, gentle, sun-shielded project. Do the boring part relentlessly and the spots fade; skip it and no serum will save them.
How pigment actually gets made
Melanin is produced by melanocytes, which sit at the base of the epidermis in roughly the same number in every human being regardless of skin tone. What differs between people is not how many melanocytes they have but how active those cells are and how the pigment they make is packaged and distributed.
The rate-limiting step is an enzyme called tyrosinase, which converts tyrosine through a series of intermediates into melanin. Nearly every topical treatment for pigmentation works by interfering with this pathway at some point, which is why the ingredients look chemically unrelated but do broadly similar things.
The finished pigment is packaged into melanosomes and handed off to surrounding keratinocytes, which carry it upward as they mature and shed. That transfer step is a second point of intervention, and it is where niacinamide is thought to act.
Three things reliably switch this machinery on: ultraviolet light, inflammation of any kind, and hormonal signalling. Almost every pigmentation problem is one of those three, and identifying which is the first useful step.
Epidermal or dermal, and why it decides everything
Pigment sitting in the epidermis behaves quite differently from pigment that has dropped into the dermis below. Epidermal pigment travels upward with the natural turnover of the skin and can be shed, which means it responds to topical treatment on a timescale of months.
Dermal pigment has crossed the basement membrane and is no longer part of that conveyor. It sits below the layer that renews itself, topical actives reach it poorly, and it fades over years rather than months if it fades at all.
Clinicians distinguish them with a Wood's lamp, under which epidermal pigment becomes more sharply defined and dermal pigment does not. At home, a rough guide is colour and edge: brown with a crisp border tends to be epidermal, greyish or bluish with a diffuse edge tends to be deeper.
This single distinction explains why two people using the same product report completely different results. It is not the product; it is where the pigment is sitting.
Post-inflammatory hyperpigmentation, in detail
This is the flat brown or grey mark left behind after a spot, a scratch, an insect bite, a burn or an aggressive cosmetic procedure. The inflammation itself stimulates melanocytes, and the mark left behind is not a scar — it is pigment sitting in skin that is otherwise intact.
It is far more common and more persistent in deeper skin tones, where melanocytes respond more readily to inflammatory signals. That is a physiological difference rather than a defect, and it changes the treatment calculus substantially: for these skin types, preventing inflammation matters more than treating pigment.
The single most important intervention is therefore treating the underlying condition rather than the mark. Continuing to pick at acne while applying a brightening serum is a losing arrangement, because new marks are being created faster than old ones fade.
Left alone with good sun protection, most post-inflammatory marks fade over three to twelve months. Treatment shortens that; nothing eliminates it, and anything claiming to do so within a fortnight is describing a different phenomenon.
Melasma is a different disease
Melasma presents as symmetrical patches across the cheeks, forehead, upper lip and jaw, most commonly in women, and it is driven by hormones as much as by light. Pregnancy and combined oral contraceptives are frequent triggers, which is why it is sometimes called the mask of pregnancy.
Critically, it responds to heat and to visible light, not only to ultraviolet. This is why melasma flares in people who are diligent about a conventional sunscreen, and why standing over a hot stove or sitting near a window can undo months of progress.
It is also chronic and relapsing by nature. Treatment controls it rather than curing it, and stopping treatment after a good result is the most common route back to where you started. Anyone approaching melasma expecting a course of treatment with an end date will be disappointed.
Aggressive treatment frequently backfires. Strong peels and lasers can worsen melasma through the inflammation they cause, and the professionals who treat it well are conspicuously cautious.
Sun spots and the accumulated-dose problem
Solar lentigines — the flat brown patches on the backs of hands, the upper chest and the temples — are the visible record of cumulative ultraviolet exposure. They are localised areas where melanocytes have become permanently more active, not simply deposits of pigment.
Because the change is in the cells themselves rather than only in the pigment they produced, these respond less predictably to topical treatment than post-inflammatory marks do. They fade, but slowly and often incompletely.
They are also the pigmentation type that responds best to procedures. Targeted laser and intense pulsed light treat them efficiently in lighter skin, and cryotherapy is used for individual lesions, though both carry pigmentation risks of their own in deeper skin tones.
Any new, changing, irregular or asymmetric pigmented lesion is a dermatologist's question rather than a skincare one. This is the one section of this subject where self-treatment is genuinely the wrong instinct.
The ingredient tiers, from shelf to prescription
The over-the-counter tier is broader than most people realise. Azelaic acid at ten per cent, niacinamide at four to five per cent, vitamin C, alpha arbutin, kojic acid, tranexamic acid and licorice root extract all have some evidence behind them, and all work slowly.
Retinoids belong in a category of their own here, because they accelerate turnover and therefore accelerate the shedding of pigmented cells while also improving the penetration of everything else. For epidermal pigment they are among the most useful things available without a prescription.
The prescription tier is where the strongest options sit. Hydroquinone remains the reference standard, typically at four per cent and used in courses of three to four months rather than indefinitely. Triple combination creams add a retinoid and a steroid, and prescription tranexamic acid is used orally for melasma in some settings.
Cysteamine is the more recent addition, available without prescription in some markets, with trial data comparable to hydroquinone and a smell that most users describe with feeling. It is worth knowing about for people who cannot use hydroquinone.
Procedures, and when they help or hurt
Chemical peels, microneedling, fractional lasers and intense pulsed light all have a place, and all of them work by controlled injury. That is precisely the mechanism that produces post-inflammatory hyperpigmentation, which makes procedure selection a matter of real consequence rather than preference.
In lighter skin with discrete sun spots, targeted light-based treatment is efficient and low-risk. In deeper skin tones, the same devices carry a meaningful risk of leaving the patient worse off, and practitioner experience with that specific skin type matters more than the equipment in the room.
For melasma the caution is universal. Aggressive resurfacing frequently triggers a rebound worse than the original, and the conservative sequence — topicals and rigorous photoprotection for several months first — is not the practitioner being slow.
A reasonable rule is that procedures accelerate a plan that is already working. They are a poor substitute for one that has not been established.
Visible light, iron oxides and the right sunscreen
Conventional SPF testing measures protection against ultraviolet only, and for most purposes that is what matters. For pigmentation, and for melasma in particular, it is insufficient, because visible light — especially the high-energy blue end — independently stimulates melanocytes in deeper skin tones.
The practical answer is a tinted sunscreen. The tint comes from iron oxides, which absorb visible light in a way that transparent filters do not, and studies have found tinted formulations outperform untinted ones for melasma specifically.
This is one of the few places in skincare where a cosmetic feature is doing pharmacological work. The tint is not there to even out your complexion, or not only; it is the active protection against the wavelengths that are driving the problem.
Combined with the usual instructions — enough of it, every day, reapplied — this is genuinely the intervention that determines whether anything else in the routine has a chance of working.
A realistic timeline, and how to see progress
Nothing in this category works in weeks. Post-inflammatory marks improve noticeably over two to three months of consistent treatment. Sun spots take longer. Melasma is managed indefinitely rather than resolved, and a good outcome is a patch that is faint rather than absent.
Progress is genuinely difficult to see day to day, which is why so many effective routines get abandoned. Take a photograph at the start, in the same place, at the same time of day, with the same light and no makeup, and repeat it monthly rather than weekly.
The comparison that matters is the one across three months, not the one across three days. Most people who conclude that nothing is working have never actually made that comparison.
And the discipline that underlies all of it is unchanged: without daily, generous, reapplied sun protection, every treatment in this article is being applied to skin that is being re-stimulated faster than it is being treated.